Weight-Adjusted vs Fixed Low Doses of Low Molecular Weight Heparin For Venous Thromboembolism Prevention in COVID-19

NCT04373707 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

1000

Enrollment

OTHER

Sponsor class

Conditions

COVID
Thrombosis
Pulmonary Embolism
Deep Vein Thrombosis

Interventions

DRUG: Enoxaparin
DRUG: Enoxaparin

Sponsor

Central Hospital, Nancy, France

Collaborators

[object Object]
[object Object]
[object Object]